Science Explorer Back to mapMap

Most cited papers from IFT Institut für Therapieforschung

What are the most cited papers from IFT Institut für Therapieforschung?

The most cited paper from IFT Institut für Therapieforschung is "Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome" (Alexander A. Zimprich, Monika Grabowski, Friedrich Asmus et al., 2001), with 485 citations. Next come "Validation of the Ten-Item Internet Gaming Disorder Test (IGDT-10) and evaluation of the nine DSM-5 Internet Gaming Disorder criteria" (431) and "Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease" (400).

Showing 50 of 61 papers. Every paper with more than 68 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome Alexander A. Zimprich, Monika Grabowski, Friedrich Asmus et al. · Nature Genetics 27 Aug 2001 485
2 Validation of the Ten-Item Internet Gaming Disorder Test (IGDT-10) and evaluation of the nine DSM-5 Internet Gaming Disorder criteria Orsolya Király, Pawel Sleczka, Halley M. Pontes et al. · Addictive Behaviors Open access 26 Nov 2015 431
3 Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease Julien Bryois et al. · Nature Genetics Open access320 authors 27 Apr 2020 400
4 Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement Bengt I. Eriksson, Lars C. Borris, O.E. Dahl et al. · Journal of Thrombosis and Haemostasis Open access 13 Dec 2005 303
5 Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes Susanne Rösner, Stefan Leucht, Philippe Lehert et al. · Journal of Psychopharmacology Review 22 Aug 2007 299
6 Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement Lars C. Borris, Ola Einar Dahl, Sylvia K. Haas et al. · Thrombosis and Haemostasis 2008 271
7 Misuse of Medicines in the European Union: A Systematic Review of the Literature Alicia Casati, Roumen Sedefov, Tim Pfeiffer-Gerschel · European Addiction Research ReviewOpen access 2012 249
8 Defining Substance Use Disorders: Do We Really Need More Than Heavy Use? Jürgen T. Rehm, Simon Marmet, Peter P. Anderson et al. · Alcohol and Alcoholism Open access 7 Aug 2013 245
9 Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery Wolfgang Mueck, Bengt I. Eriksson, Kenneth Alan Bauer et al. · Clinical Pharmacokinetics 2008 243
10 Handbook of Implicit Cognition and Addiction Gerhard Bühringer · Addiction 22 May 2007 235
11 Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology Hans Gollwitzer · Journal of Antimicrobial Chemotherapy Open access 28 Jan 2003 215
12 Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation Sebastian Edgar Baumeister, Henry Völzke, Paul Marschall et al. · Gastroenterology Open access 9 Nov 2007 210
13 CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities Robin J.M. Franklin, Mikael Simons · Neuron Open access 12 Oct 2022 190
14 Prevalence of and Potential Influencing Factors for Alcohol Dependence in Europe Jürgen T. Rehm, Peter P. Anderson, Joe M. Barry et al. · European Addiction Research Open access 18 Oct 2014 187
15 Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study Michael Soyka, Christina Zingg, Gabriele Koller et al. · The International Journal of Neuropsychopharmacology Open access 21 Jan 2008 186
16 What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention Hans‐Ulrich Wïttchen, Silke Behrendt, Michael Höfler et al. · International Journal of Methods in Psychiatric Research Open access 2008 173
17 Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012 Alexander Pabst, Ludwig Kraus, Elena Gomes de Matos et al. · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice Open access 2013 173
18 Group Psychotherapy of Dysfunctional Fear of Progression in Patients with Chronic Arthritis or Cancer Peter Herschbach, Petra Berg, Sabine Waadt et al. · Psychotherapy and Psychosomatics 4 Nov 2009 162
19 Non‐medical use of prescription opioids and prescription opioid‐related harms: why so markedly higher in N orth A merica compared to the rest of the world? Benedikt Fischer, Annette Keates, Gerhard Bühringer et al. · Addiction 20 May 2013 148
20 O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes Friederike C. Rau, Wolfgang Weber, Hans‐Jürgen Wester et al. · European Journal of Nuclear Medicine and Molecular Imaging 28 May 2002 142
21 Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits Eva Hoch, Nora D. Volkow, Chris M. Friemel et al. · European Archives of Psychiatry and Clinical Neuroscience Open access 19 Sep 2024 132
22 The Use of Alcohol, Tobacco, Illegal Drugs and Medicines Josefine Atzendorf, Christian Rauschert, Nicki‐Nils Seitz et al. · Deutsches Ärzteblatt international Open access 26 Aug 2019 132
23 Polychrome labeling of bone with seven different fluorochromes: Enhancing fluorochrome discrimination by spectral image analysis Christoph Pautke, Stephan Vogt, Thomas Tischer et al. · Bone 20 Jul 2005 126
24 Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor Achim Krüger, Matthias Arlt, Michael Gerg et al. · Cancer Research May 2005 125
25 Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents Stéphane Legleye, Daniela Piontek, Ludwig Kraus · Drug and Alcohol Dependence 24 Sep 2010 124
26 Combined Reporter Gene PET and Iron Oxide MRI for Monitoring Survival and Localization of Transplanted Cells in the Rat Heart Takahiro Higuchi, Martina Anton, Katja Dumler et al. · Journal of Nuclear Medicine Open access 12 Jun 2009 122
27 Short scales to assess cannabis-related problems: a review of psychometric properties Daniela Piontek, Ludwig Kraus, Danica Klempová · Substance Abuse Treatment Prevention and Policy Open access Dec 2008 122
28 Estimating prevalence of problem drug use at national level in countries of the European Union and Norway Ludwig Kraus, Rita Augustin, Martin Frischer et al. · Addiction 25 Mar 2003 122
29 Why are young people drinking less than earlier? Identifying and specifying social mechanisms with a pragmatist approach Jukka Törrönen, Filip Roumeliotis, Eva Samuelsson et al. · International Journal of Drug Policy Open access 10 Dec 2018 118
30 Second generation of meniscus transplantation: in-vivo study with tissue engineered meniscus replacement Vladimir Martinek, Peter Ueblacker, Katharina Braun et al. · Archives of Orthopaedic and Trauma Surgery 7 Oct 2005 113
31 Long waves of consumption or a unique social generation? Exploring recent declines in youth drinking Ludwig Kraus, Robin Room, Michael Livingston et al. · Addiction Research & Theory 7 Jul 2019 110
32 The urokinase plasminogen activator system as a novel target for tumour therapy Manfred Schmitt, Olaf G. Wilhelm, Ute Reuning et al. · Fibrinolysis and Proteolysis Mar 2000 108
33 Prevalence of youth gambling and potential influence of substance use and other risk factors throughout 33 European countries: first results from the 2015 ESPAD study Sabrina Molinaro, Elisa Benedetti, Marco Scalese et al. · Addiction 28 May 2018 102
34 Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology Jürgen Rehm, Robin Room, Wim van den Brinkt et al. · European Neuropsychopharmacology 14 Jun 2005 100
35 Why Do Young People Start Drinking? Motives for First-Time Alcohol Consumption and Links to Risky Drinking in Early Adolescence Emmanuel N. Kuntsche, Stefanie Müller · European Addiction Research 3 Dec 2011 99
36 Defining key concepts for mental state attribution François Quesque et al. · Communications Psychology Open access 11 Apr 2024 96
37 Patient goals in post-acute geriatric rehabilitation - goal attainment is an indicator for improved functioning Eva Grill, Sandra Kus, M M uuml ller et al. · Journal of Rehabilitation Medicine Open access 2011 91
38 Measuring alcohol consumption and alcohol‐related problems: comparison of responses from self‐administered questionnaires and telephone interviews Ludwig Kraus, Rita Augustin · Addiction Mar 2001 88
39 Awareness of alcohol as a risk factor for cancer is associated with public support for alcohol policies Sarah E. Bates, John Holmes, Lucy Gavens et al. · BMC Public Health Open access 4 Jun 2018 84
40 Association of Average Daily Alcohol Consumption, Binge Drinking and Alcohol-Related Social Problems: Results from the German Epidemiological Surveys of Substance Abuse Ludwig Kraus, Sebastian‐Edgar Baumeister, Alexander Pabst et al. · Alcohol and Alcoholism 15 Jan 2009 84
41 Age, Period and Cohort Effects on Time Trends in Alcohol Consumption in the Swedish Adult Population 1979–2011 Ludwig Kraus, Mimmi Eriksson Tinghög, Annette Lindell et al. · Alcohol and Alcoholism 5 Mar 2015 84
42 A test system for gas sensors H.-E. Endres, Hildegard D. Jander, Wolfgang Göttler · Sensors and Actuators B Chemical Feb 1995 83
43 Prevalence of alcohol use and the association between onset of use and alcohol‐related problems in a general population sample in Germany Ludwig Kraus, Kim Bloomfield, Rita Augustin et al. · Addiction Sep 2000 83
44 Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients Hans‐Ulrich Wïttchen, Sabine M. Apelt, Michael Soyka et al. · Drug and Alcohol Dependence Open access 14 Mar 2008 83
45 A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain Martin Frischer, Matthew Hickman, Ludwig Kraus et al. · Addiction Oct 2001 82
46 Cognitive Functioning During Methadone and Buprenorphine Treatment Michael Soyka, Martin Lieb, Sabine Kagerer et al. · Journal of Clinical Psychopharmacology 12 Nov 2008 81
47 CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial Eva Hoch, Gerhard Bühringer, A Pixa et al. · Drug and Alcohol Dependence 8 Oct 2013 80
48 Trends in Substance Use and Related Disorders Nicki‐Nils Seitz, Kirsten Lochbühler, Josefine Atzendorf et al. · Deutsches Ärzteblatt international Open access 26 Aug 2019 79
49 Experimental basis and first application of clinical lymph vessel transplantation of secondary lymphedema R. G. H. Baumeister, Jürgen Scifert, Baldur Wiebecke et al. · World Journal of Surgery May 1981 78
50 Why Is Per Capita Consumption Underestimated in Alcohol Surveys? Results from 39 Surveys in 23 European Countries Carolin Kilian, Jakob Manthey, Charlotte Probst et al. · Alcohol and Alcoholism Open access 5 May 2020 77

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.